Latest news
Medicare Coverage Granted for Veracyte’s Test for Muscle-Invasive Bladder Cancer - Medical Product OutsourcingMedical Product Outsourcing · Tue, 04 Aug 2026 15:14:53 GMTMetastatic HRR-altered hormone-sensitive prostate cancer: add talazoparib to enzalutamide - Vera HealthVera Health · Thu, 30 Jul 2026 03:53:13 GMTEnzalutamide Plus Leuprolide Improves Overall Survival in High-Risk Biochemically Recurrent Prostate Cancer - Vera HealthVera Health · Tue, 28 Jul 2026 09:07:41 GMT